Literature DB >> 16018151

The behavioural neurology assessment.

S Darvesh1, L Leach, S E Black, E Kaplan, M Freedman.   

Abstract

BACKGROUND: We present information regarding the standardization, reliability and clinical validity of two versions of the Behavioural Neurology Assessment (BNA). The BNA-Long Form consists of 24 subtests within separate domains: Attention, Memory, Language, Visuospatial Function, Executive Function, and Praxis. The BNA-Short Form consists of 13 subtests within the domains of Attention, Memory, Naming, Visuospatial Function and Executive Function. In addition to individual domain indices, a Grand Total score was calculated for both BNA versions.
OBJECTIVE: To standardize the administration and scoring and validate the BNA for detection of dementia.
METHODS: Standardized normative data were obtained on 115 healthy subjects ranging in age from 50 to 95. Test-retest stability was obtained on 19 subjects and clinical validity was investigated by administering the BNA and Mini-Mental Status Examination (MMSE) to 29 patients with dementia and 29 age-matched healthy subjects (controls).
RESULTS: Age had a significant effect on all but the Visuospatial and Praxis indices of the BNA-Long Form and an effect on Naming and Grand Total score of the Short-Form. Internal consistency (Cronbach's coefficient alpha) was .87 and .67 for the Long and Short Forms (.95 and .96 for dementia and control groups combined). Test-retest stability was acceptable. Grand Total indices of both BNA versions showed significant, positive correlations with the MMSE. Both BNA versions had superior sensitivity to dementia relative to the MMSE (.93 versus .79). Specificity was equivalent to the MMSE (.93 versus .97).
CONCLUSIONS: Positive predictive values of the BNA and MMSE are equivalent but the BNA provides superior negative predictive value.

Entities:  

Mesh:

Year:  2005        PMID: 16018151     DOI: 10.1017/s0317167100003930

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

1.  Reversible long-standing severe disability in idiopathic normal pressure hydrocephalus.

Authors:  Ayman M Selim; Colleen Ray; Michael D Cusimano; Eloise Karp; Morris Freedman
Journal:  Neurol Clin Pract       Date:  2015-12

2.  Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.

Authors:  Ming Zhang; Allison A Dilliott; Roaa Khallaf; John F Robinson; Robert A Hegele; Michael Comishen; Christine Sato; Giuseppe Tosto; Christiane Reitz; Richard Mayeux; Peter St George-Hyslop; Morris Freedman; Ekaterina Rogaeva
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

Review 3.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

Review 4.  The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature.

Authors:  Pierre Sinajon; Deborah Verbaan; Joyce So
Journal:  Hum Genet       Date:  2016-05-03       Impact factor: 4.132

5.  Kynurenines and other novel therapeutic strategies in the treatment of dementia.

Authors:  Zsófia Majláth; János Tajti; László Vécsei
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

6.  Determining the association of medical co-morbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review.

Authors:  Corinne E Fischer; Depeng Jiang; Tom A Schweizer
Journal:  BMC Geriatr       Date:  2010-12-17       Impact factor: 3.921

7.  The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics.

Authors:  Richard H Swartz; Megan L Cayley; Krista L Lanctôt; Brian J Murray; Ashley Cohen; Kevin E Thorpe; Michelle N Sicard; Karen Lien; Demetrios J Sahlas; Nathan Herrmann
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

8.  Profile of cognitive complaints in vascular mild cognitive impairment and mild cognitive impairment.

Authors:  Jenny Gu; Corinne E Fischer; Gustavo Saposnik; Tom A Schweizer
Journal:  ISRN Neurol       Date:  2013-10-28

9.  Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

Authors:  Maria Martinez; Namita Multani; Cassandra J Anor; Karen Misquitta; David F Tang-Wai; Ron Keren; Susan Fox; Anthony E Lang; Connie Marras; Maria C Tartaglia
Journal:  Front Aging Neurosci       Date:  2018-04-24       Impact factor: 5.750

10.  MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.

Authors:  Paul M McKeever; Raphael Schneider; Foad Taghdiri; Anna Weichert; Namita Multani; Robert A Brown; Adam L Boxer; Anna Karydas; Bruce Miller; Janice Robertson; Maria Carmela Tartaglia
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.